Evidence map›Paper›PMID 42818222›Full record

ArticlebioRxiv : the preprint server for biology2026

Lactate Receptor Activation Alleviates Senescence and Preserves Homeostasis of Aged Arteries.

Yulun Wu, Hamsa Vardini Senthil Kumar, Sai Harsha Bhamidipati, Haibo Yu, Pihu Mehrotra, Pedro Lei, Arundhati Das, Patrick Saari, Maryam Elsayed, Linzhang Huang and 1 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Yulun WuDepartment of Chemical and Biological Engineering, University at Buffalo, State University of New York, Buffalo, NY 14260, USA.ORCID 0009-0007-4039-0356
Hamsa Vardini Senthil KumarDepartment of Chemical and Biological Engineering, University at Buffalo, State University of New York, Buffalo, NY 14260, USA.
Sai Harsha BhamidipatiDepartment of Chemical and Biological Engineering, University at Buffalo, State University of New York, Buffalo, NY 14260, USA.
Haibo YuShanghai Key Laboratory of Metabolic Remodeling and Health, Institute of Metabolism and Integrative Biology, Shanghai, 200438, China.
Pihu MehrotraDepartment of Chemical and Biological Engineering, University at Buffalo, State University of New York, Buffalo, NY 14260, USA.
Pedro LeiDepartment of Chemical and Biological Engineering, University at Buffalo, State University of New York, Buffalo, NY 14260, USA.
Arundhati DasDepartment of Chemical and Biological Engineering, University at Buffalo, State University of New York, Buffalo, NY 14260, USA.
Patrick SaariDepartment of Chemical and Biological Engineering, University at Buffalo, State University of New York, Buffalo, NY 14260, USA.
Maryam ElsayedDepartment of Chemical and Biological Engineering, University at Buffalo, State University of New York, Buffalo, NY 14260, USA.
Linzhang HuangShanghai Key Laboratory of Metabolic Remodeling and Health, Institute of Metabolism and Integrative Biology, Shanghai, 200438, China.
Stelios T AndreadisDepartment of Chemical and Biological Engineering, University at Buffalo, State University of New York, Buffalo, NY 14260, USA.ORCID 0000-0001-9885-0457

Funding

Restoring the regenerative capacity of the aged muscleR01AG068250 · NIA · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI ANDREADIS, STELIOS THEOHARIS · 2020 to 2024
$2.0M
NIA NIH HHS R01 AG068250
6 · The paper itself

Abstract

Arteries are among the first tissues to exhibit age-related dysfunction, yet the metabolic mechanisms driving vascular senescence remain poorly understood. Here, analysis of human aortic transcriptomic data identified HCAR1, encoding the lactate receptor GPR81, as one of the genes most significantly downregulated with age. We therefore investigated whether age-associated loss of GPR81 contributes to cellular senescence within the vessel wall. Senescent human endothelial cells and vascular smooth muscle cells accumulated neutral and oxidized lipids and exhibited increased labile iron and ferroptosis. Silencing GPR81 in early-passage cells recapitulated this metabolic phenotype together with multiple hallmarks of cellular senescence. Moreover, endothelial-specific deletion of GPR81 in young mice was sufficient to induce senescent cell accumulation, impaired lipid homeostasis, endothelial dysfunction, and elastin disorganization. Conversely, pharmacological activation of GPR81 with the agonist CHBA restored fatty acid metabolism, promoted glycolytic reprogramming, and attenuated ferroptotic stress and senescence-associated phenotypes. In lamin A knock-in (LAKI) progeroid mice, CHBA reduced arterial lipid accumulation and cellular senescence, shifted vascular cell composition toward a youthful state, improved endothelial integrity, and restored extracellular matrix homeostasis. Together, these findings identify age-associated loss of GPR81 as a driver of vascular metabolic dysfunction and cellular senescence and establish pharmacological GPR81 activation as a promising therapeutic strategy for preserving vascular homeostasis and mitigating age-associated cardiovascular disease.

Identifiers

PMID42818222
PMCPMC13622169

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.